MX2015014265A - Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel. - Google Patents

Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel.

Info

Publication number
MX2015014265A
MX2015014265A MX2015014265A MX2015014265A MX2015014265A MX 2015014265 A MX2015014265 A MX 2015014265A MX 2015014265 A MX2015014265 A MX 2015014265A MX 2015014265 A MX2015014265 A MX 2015014265A MX 2015014265 A MX2015014265 A MX 2015014265A
Authority
MX
Mexico
Prior art keywords
glutamine
hyaluronic acid
alanine
skin lesions
healing wounds
Prior art date
Application number
MX2015014265A
Other languages
English (en)
Other versions
MX358845B (es
Inventor
Nathalie Castex-Rizzi
Hélène Duplan
Corinne Dechelette
Laetitia Bonzom
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MX2015014265A publication Critical patent/MX2015014265A/es
Publication of MX358845B publication Critical patent/MX358845B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers & Plastics (AREA)

Abstract

La presente invención se refiere a una combinación que comprende el dipéptido L-alanil-L-5 glutamina, ácido hialurónico o una de las sales del mismo y un extracto de avena, destinada ventajosamente para la curación de heridas y la reparación de lesiones de la piel.
MX2015014265A 2013-04-10 2014-04-10 Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel. MX358845B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1353231A FR3004353B1 (fr) 2013-04-10 2013-04-10 Association synergique de l'alanine-glutamine, l'acide hyaluronique et un extrait d'avoine, et son utilisation dans une composition destinee a la cicatrisation et la reparation des lesions cutanees
PCT/EP2014/057224 WO2014167039A1 (fr) 2013-04-10 2014-04-10 Association synergique de l'alanine-glutamine, l'acide hyaluronique et un extrait d'avoine et son utilisation dans une composition destinee a la cicatrisation et la reparation des lesions cutanees

Publications (2)

Publication Number Publication Date
MX2015014265A true MX2015014265A (es) 2016-03-01
MX358845B MX358845B (es) 2018-09-05

Family

ID=48741402

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014265A MX358845B (es) 2013-04-10 2014-04-10 Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel.

Country Status (18)

Country Link
US (1) US9849154B2 (es)
EP (1) EP2983691B1 (es)
JP (1) JP2016515642A (es)
KR (1) KR102202391B1 (es)
CN (1) CN105101984B (es)
AU (1) AU2014253131B2 (es)
BR (1) BR112015024920A2 (es)
CA (1) CA2908628C (es)
DK (1) DK2983691T3 (es)
ES (1) ES2661908T3 (es)
FR (1) FR3004353B1 (es)
HK (1) HK1212924A1 (es)
MX (1) MX358845B (es)
NO (1) NO2983691T3 (es)
PL (1) PL2983691T3 (es)
PT (1) PT2983691T (es)
RU (1) RU2665371C2 (es)
WO (1) WO2014167039A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3066693B1 (fr) * 2017-05-24 2020-12-18 Fabre Pierre Dermo Cosmetique Composition pour le remodelage des cicatrices
KR101899413B1 (ko) * 2018-05-03 2018-09-18 주식회사 케어사이드 피부 감염의 예방 또는 치료용 조성물
US10500318B1 (en) * 2018-07-03 2019-12-10 Temple Therapeutics BV Dosing regimens for treating hypoxia-associated tissue damage
KR102022400B1 (ko) * 2019-04-30 2019-09-18 (주)진셀팜 천연 복합 추출물을 유효성분으로 함유하는 안티폴루션 화장료 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6368579B1 (en) * 2000-08-08 2002-04-09 Teresa Leigh Barr Oat protein complex sunblock and method of use
US8075920B2 (en) * 2006-05-11 2011-12-13 Regenics A/S Administration of cells and cellular extracts for rejuvenation
FR2926461B1 (fr) * 2008-01-23 2010-03-05 Jean Noel Thorel Nouveau facteur de croissance cellulaire d'origine non animale et applications
FR2938439B1 (fr) 2008-11-14 2013-03-01 Fabre Pierre Dermo Cosmetique Extrait de parties aeriennes d'avoine recoltees avant epiaison
DE102009029813A1 (de) * 2009-06-18 2010-12-23 Henkel Ag & Co. Kgaa Antifalten-Kosmetikum
CN101816620B (zh) * 2010-03-12 2011-07-20 广州舒泰生物技术有限公司 一种美白化妆品及其制备方法和应用
JP2013533867A (ja) * 2010-06-28 2013-08-29 アデセラピューティクス インコーポレイテッド ケロイド治療
DE102010027180A1 (de) * 2010-07-14 2011-05-26 Henkel Ag & Co. Kgaa Nicht-therapeutische Verwendung zum Stammzellenschutz
JP2012240993A (ja) * 2011-05-24 2012-12-10 Q P Corp 肌弾力性改善剤
FR2977494B1 (fr) * 2011-07-08 2013-08-16 Ayawane Compositions cosmetiques ou pharmaceutiques contenant des acides hyaluroniques de masses moleculaires differentes

Also Published As

Publication number Publication date
MX358845B (es) 2018-09-05
BR112015024920A2 (pt) 2017-07-18
CA2908628C (fr) 2021-06-08
RU2015142443A (ru) 2017-05-19
NO2983691T3 (es) 2018-05-12
US20160303181A1 (en) 2016-10-20
FR3004353B1 (fr) 2015-05-15
JP2016515642A (ja) 2016-05-30
CN105101984A (zh) 2015-11-25
US9849154B2 (en) 2017-12-26
HK1212924A1 (zh) 2016-06-24
PL2983691T3 (pl) 2018-05-30
ES2661908T3 (es) 2018-04-04
KR102202391B1 (ko) 2021-01-12
AU2014253131A1 (en) 2015-11-05
EP2983691A1 (fr) 2016-02-17
DK2983691T3 (en) 2018-03-19
CN105101984B (zh) 2018-06-01
EP2983691B1 (fr) 2017-12-13
WO2014167039A1 (fr) 2014-10-16
RU2665371C2 (ru) 2018-08-29
CA2908628A1 (fr) 2014-10-16
PT2983691T (pt) 2018-03-22
AU2014253131B2 (en) 2018-11-15
KR20150140319A (ko) 2015-12-15
FR3004353A1 (fr) 2014-10-17

Similar Documents

Publication Publication Date Title
CA2897514C (en) Nanofibrillar polysaccharide for use in the control and prevention of contraction and scarring
PH12015502042A1 (en) Use of linagliptin in cardio-and renoprotective antidiabetic therapy
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
BR112015011756A2 (pt) inibidores da glutamase e métodos de uso
MX2021001169A (es) Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas.
IL257057A (en) Biologically active peptides derived from soy for use in preparations and methods for wound healing, tissue engineering and regenerative medicine
EP3328414A4 (en) COMPOSITION FOR USE IN PROMOTING WOUND HEALING
HK1215540A1 (zh) 用於治療或預防疾病的因子 蛋白、因子 蛋白及其抑制劑
MX2020011880A (es) Regeneracion de tejido da?ado.
BR112015023987A2 (pt) creme dental de duas fases
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
MX2018007871A (es) Composiciones para el cuidado personal.
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
PH12015502405B1 (en) Methods and compositions for wound healing
MX2014010940A (es) El uso de antitrombina en el tratamiento de preeclampsia.
AU350280S (en) Apparatus for skin treatment
BR112014000795A2 (pt) uso cosmético e/ou dermatológico de compostos oligossacarídeos na prevenção e no tratamento de estrias
MX358845B (es) Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel.
MX2015013755A (es) Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis.
SG11201509173WA (en) Alpha adrenergic agonists for in the treatment of tissue trauma
MX2016005473A (es) Metodos y composiciones para mejorar la funcion renal.
NZ711523A (en) Use of sedoheptulose for prevention or treatment of inflammation
EP3380092A4 (en) COMPOSITION OF OLIVETOL AND METHOD FOR REDUCING OR INHIBITING THE EFFECT OF TETRAHYDROCANNABINOL IN THE HUMAN BODY
MX2015014063A (es) Composicion anti tumoral que comprende un inhibidor selectivo pi3kbeta y un inhibidor selectivo pi3kalfa.
AU350994S (en) Medical stopcock

Legal Events

Date Code Title Description
FG Grant or registration